Hypertension. Essential (primary) hypertension
Conditions
Interventions
Intervention 1: Intervention group: The drug application is installed on the intervention group's mobile phone, and reminders about when to take the drugs will be set. Intervention 2: Control group:
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
60 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age between 60-74 years old Conscious consent to enter the study Taking more than five types of medication during the day Reading and writing literacy Having a smart phone and the ability to use it Ability to communicate and not having dementia Having any of the following diseases: hypertension, diabetes, chronic obstructive pulmonary disease (COPD) Use only the drug form of the tablet (Tab) in the drug program
Exclusion criteria
Exclusion criteria: Reluctance to continue participating in the study Hospitalization or death of the participats Use of rare, expensive and special drugs Use of injectable drugs (such as insulin in diabetes)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug adherence. Timepoint: In the present study, Morisky Adherence Questionnaire (MAQ) will be completed by both control and intervention groups before the start of the study and after 8 weeks from the beginning of the study. Method of measurement: Morisky Adherence Questionnaire (MAQ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug consequences. Timepoint: In the present study, a researcher-made questionnaire on drug consequences before and 8 weeks after the intervention will be completed by the control and intervention groups. Method of measurement: researcher-made drug consequences questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahzad Pashaeypoor
Tehran University of Medical Sciences
Outcome results
None listed